Your session is about to expire
← Back to Search
Prevention of Readmissions at IBD Centres of Excellence (PRICE Trial)
N/A
Waitlist Available
Led By Geoffrey Nguyen, MD, PhD
Research Sponsored by Mount Sinai Hospital, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post-discharge
Awards & highlights
No Placebo-Only Group
Summary
Patients with Inflammatory Bowel Disease (IBD) are frequently hospitalized, with an increased risk of repeat hospitalizations within the same calendar year. Given that hospital readmissions represent a significant burden to patients and the health care system, a standardised pathway for IBD patients discharged from the hospital can have a significant impact on reducing readmission rates, healthcare utilization and patient satisfaction. The primary aim of this study is to evaluate the effectiveness of an IBD post-discharge pathway, involving post-discharge nurse follow-up and electronic monitoring, in reducing IBD readmission rates.
Eligible Conditions
- Crohn's Disease
- Inflammatory Bowel Disease
- Ulcerative Colitis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days post-discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post-discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Post-Discharge Readmission
Secondary study objectives
Disease Activity
IBD related Quality of Life
Patient Satisfaction with 'Health Promise'
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Nurse Follow-Up and Electronic MonitoringExperimental Treatment4 Interventions
Group II: Minimal InterventionActive Control2 Interventions
Find a Location
Who is running the clinical trial?
Mount Sinai Hospital, CanadaLead Sponsor
204 Previous Clinical Trials
68,797 Total Patients Enrolled
Crohn's and Colitis CanadaOTHER
7 Previous Clinical Trials
907 Total Patients Enrolled
Geoffrey Nguyen, MD, PhDPrincipal InvestigatorMount Sinai Hospital, Canada
1 Previous Clinical Trials
150 Total Patients Enrolled